-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 17, the 4th Parkinson's Disease National Summit Forum hosted by Lingbei China was held in Hangzhou.
The survey is a research project focusing on the quality of life of Parkinson's disease patients.
China's Parkinson's disease patients will reach 5 million, and "physical and mental dilemma" becomes the main treatment problem
China's Parkinson's disease patients will reach 5 million, and "physical and mental dilemma" becomes the main treatment problemParkinson's disease is the second most common neurodegenerative disease after Alzheimer's disease.
In the early stage of the treatment of Parkinson's disease, the drug treatment has a significant and long-lasting effect, and the patient seems to have returned to the previous healthy state.
"In the pre-clinical stage of Parkinson's disease, patients often do not have specific symptoms, such as shaking and slow movements, but there are still many clues at this time, such as constipation, decreased sense of smell, sleep disorders, anxiety and depression, etc.
"With the progression of Parkinson's disease, patients may gradually lose the ability to work and take care of themselves.
The development process of Parkinson's disease can reach 20-30 years, and long-term benefits can only be achieved by full management.
The development process of Parkinson's disease can reach 20-30 years, and long-term benefits can only be achieved by full management.
The earlier scientific intervention of Parkinson's disease, the better.
"Parkinson's disease is no longer considered a disease that only affects the brain area that regulates movement, but a multi-system involvement disease that affects movement and many other functions.
Focus on the real needs of patients, so that the pain of life is no longer heavier than the pain of disease
Focus on the real needs of patients, so that the pain of life is no longer heavier than the pain of diseaseParkinson's disease is a common disease for people over 65 years old.
Parkinson's disease also brings heavy care and economic burdens to patients' families and society.
The suffering of life is heavier than the pain of disease is a real situation that many Parkinson's disease patients are experiencing.
Parkinson's disease is a highly disabling disease that seriously affects the quality of life.
